. Activation of NF-кB by TNFα.
DSB-repair was examined by the use of the EGFP-based test system as described in Akyüz et al. (9) To determine DSB-repair frequencies, K562(Δ/3′) cells were transfected via electroporation (Bio-Rad Laboratories, Hercules, CA, USA) with pCMV-I-SceI, pBS or wtEGFP expression plasmid and pcDNA3.0-IкBα-SR or empty vector. Cells were split into two aliquots and cultivated for 24h when etoposide, camptothecin, or doxorubicin (Sigma-Aldrich, München, Germany) were added at the indicated concentration. Transfected cells were cultivated for another 24h (B) and 48h (A,C), when they were analysed flow cytometrically for EGFP-positivity. DSB repair frequencies were determined as the fraction of green fluorescent cells compared to the total cell population and normalized in each case with the individual transfection efficiency. DSB-repair frequencies in mock-treated controls were defined as 100% each (absolute mean value: 1 x 10 -3 ) ; *P<0.05; **P<0.01. Genomic PCR conditions and PCR-1 specific primers were essentially as described in Akyüz et al. (9) As controls we amplified a 0.3 kb genomic DNA fragment within the RARα gene by use of the following oligonucleotides: 5´-AGGAGGAGATCTATCGATAGTGGCCGGCTTTGAATATCCTG-3´ and 5´-GCTGCTAGATCTATCGATAAGCCT-CCAGCACCCCATCACT-3´. To compare I-SceI mediated cleavage as a function of NF-кB, we co-transfected cells with I-SceI expression plasmid or empty vector and p65 expression plasmid or empty vector (as in Figure 3) and isolated genomic DNA 4h after transfection. In addition, we transfected cells with or without I-SceI, cultivated the cells for 24h, then treated with 10 ng/ml TNFα (as in Figure 1 ) and harvested cells after re-incubation for 8h.
Mutated (B) K562(Δ/3´) cells were transfected with 10 µg pCMV-I-SceI, 10µg pBS/wtEGFP plasmid, and 40 µg pcDNA3.0-p65 (p65) or pcDNA3.0 (Control), followed by cultivation for 72h. Subsequently, cells were FACS sorted for green EGFP-positivity and white EGFP-negativity. Genomic DNA was isolated and PCR performed with primers encompassing Δ-EGFP as previously described (9,10). As internal control, we amplified a genomic LMO2 fragment with the following primers: 5´-AGGAGGAGATCTATCGAT-3´ and 5´-GCTGCTAGATCTATCGAT-3´ (Thermo Scientific). In order to detect copies of substrate Δ-EGFP/3´EGFP that had undergone error-prone NHEJ in white cells and HR in green cells, nested PCR1a was performed on the respective PCR1 amplification product (PCR1a-specific, 3´ positioned primer: 5'-ACCTTGATGCCGTTCTTCTG-3'). PCR1a amplification product (Loading control) was then restriction digested by I-SceI or the control enzyme XhoI. The I-SceI resistant PCR1a band was quantified and normalized with the amount of DNA each. P, positive plasmid control; U, untransfected; Unsorted, transfected but unsorted; asterisk, additional, unspecific PCR1a band;
(C) WTK1(HR/3´) cells, carrying chromosomally integrated DSB repair substrate HR-EGFP/3´EGFP, were subjected to genomic PCR and restriction analysis as K562(Δ/3´) cells in (B). As internal control, we amplified a genomic RARα fragment as in Supplementary Figure S4A . Lymphoblastoid cell lines derived from patients with mutations in BRCA2 (GM13023A) or BRCA1 (HA166) and control cells from a healthy individual (416MI) were described previously (Keimling et al., 2011; 20) . Cells were electroporated with 10μg pCMV-I-SceI, 10 μg HR-EGFP/5′EGFP repair substrate, 10μg pBS/wtEGFP, and 20μg pcDNA3.0-p65 (p65) or pcDNA3.0 (Control). Then, cells were cultivated for additional 48h, when they were FACS analysed for EGFP positivity. Mean values of 416MI controls without p65 expression were taken as 100% each (absolute mean value: 0.3 x 10 -2 ). Columns, mean values of N = 6; bars, SEM; ***P<0.001.
